Skip to main
MDAI

MDAI Stock Forecast & Price Target

MDAI Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Spectral AI is expected to generate significant revenue by 1st half of 2026 with its existing BARDA contract and commercial launch of DeepView System. The company has a strong potential to improve patient outcomes and efficiency of clinical studies in the large and under-penetrated Advanced Wound Care market. With a projected annual revenue growth rate of 69% and a license model expected to drive recurring revenue at high margins, Spectral AI has the potential to become a stable and growing company in the MedTech industry.

Bears say

Spectral AI is currently facing delays and uncertainty in its revenue guidance, making it difficult for investors to accurately assess the company's financial performance. Additionally, the company's reliance on a single indication (burns) and one government contract (BARDA PBS) could make it vulnerable to changes in the regulatory and political climate. Furthermore, the company's current valuation seems inflated compared to its peers, making it a risky investment option for those looking for long-term growth.

MDAI has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Spectral AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Spectral AI Inc (MDAI) Forecast

Analysts have given MDAI a Strong Buy based on their latest research and market trends.

According to 1 analysts, MDAI has a Strong Buy consensus rating as of May 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Spectral AI Inc (MDAI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.